Bayer AG CEO Praises New Chinese Government's Focus On Health Issues
This article was originally published in PharmAsia News
Bayer AG CEO Marijn Dekkers expressed gratitude that China's leaders focused on health, nutrition and efficiency of resources at the just-ended Communist Party Congress.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.